Hu, Dale J
Kim, Jerome H
Kotloff, Karen L
Koup, Richard A
Marovich, Mary A
McElrath, M Juliana
Read, Sarah W
Robb, Merlin L
Renzullo, Philip O
D'Souza, M Patricia
MetadataShow full item record
AbstractThe rapid development of COVID-19 vaccines and their deployment in less than a year is an unprecedented scientific, medical, and public health achievement. This rapid development leveraged knowledge from decades of HIV/AIDS research and advances. However, the search for an HIV vaccine that would contribute to a durable end to the HIV pandemic remains elusive. Here, we draw from the US government experience and highlight lessons learned from COVID-19 vaccine development, which include the importance of public-private partnerships, equitable inclusion of populations impacted by the infectious pathogen, and continued investment in basic research. We summarize key considerations for an accelerated and re-energized framework for developing a safe and efficacious HIV vaccine.
Rights/Terms© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19667
- HIV and SARS-CoV-2: Tracing a Path of Vaccine Research and Development.
- Authors: Shepherd BO, Chang D, Vasan S, Ake J, Modjarrad K
- Issue date: 2022 Feb
- Individual health behaviours to combat the COVID-19 pandemic: lessons from HIV socio-behavioural science.
- Authors: Haberer JE, van der Straten A, Safren SA, Johnson MO, Amico KR, Del Rio C, Andrasik M, Wilson IB, Simoni JM
- Issue date: 2021 Aug
- The Race for Global Equitable Access to COVID-19 Vaccines.
- Authors: Md Khairi LNH, Fahrni ML, Lazzarino AI
- Issue date: 2022 Aug 12
- The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
- Authors: Amanpour S
- Issue date: 2021 Mar